Literature DB >> 17391160

A diabetes risk score helps identify metabolic syndrome and cardiovascular risk in Indians - the Chennai Urban Rural Epidemiology Study (CURES-38).

V Mohan1, S Sandeep, M Deepa, K Gokulakrishnan, M Datta, R Deepa.   

Abstract

AIMS: The aims of the study were to compare the recently evolved Indian Diabetes Risk Score (IDRS), in subjects with different grades of glucose intolerance and to evaluate its usefulness as an indicator of cardiovascular risk in Asian Indians, a high risk group for diabetes and coronary artery disease (CAD).
METHODS: The data for the present study were obtained from the Phase 3 (n = 2350, response rate: 90.4%) of the Chennai Urban Rural Epidemiology Study, a population-based study done in Chennai, the largest city in southern India. IDRS was developed based on multiple logistic regression analysis using four simple parameters namely age, abdominal obesity, family history of type 2 diabetes and physical activity. In all subjects, family history of diabetes was obtained, and details on physical activity were assessed using a validated questionnaire. Subjects with an IDRS of <30 was categorized as low risk, 30-50 as medium risk and those with > or =60 as high risk for diabetes. Biochemical and anthropometric measurements were done using standardized procedures. Minnesota coding was used to grade 12-lead electrocardiogram.
RESULTS: The mean IDRS increased significantly with worsening glucose intolerance [normal glucose tolerance (NGT) subjects: 48 +/- 17, impaired glucose tolerance (IGT): 57 +/- 16, newly diagnosed diabetics (NDD): 61 +/- 15 and known diabetics (KD): 68 +/- 12; p for trend <0.001]. Among NGT group, the prevalence of cardiovascular risk factors increased progressively in low-, medium- to high-risk score groups; hypertension: 9.4, 22.1 and 38.2% (p for trend: < 0.001), hypertriglyceridemia: 8.8, 19.9 and 25.3% (p for trend: < 0.001), hypercholesterolemia: 7.2, 20.3 and 34.9% (p for trend: < 0.001) and metabolic syndrome: 1.8, 14.6 and 30.3% (p for trend: < 0.001), respectively. The prevalence of CAD was also significantly higher in individuals with high risk compared with those with low risk (p = 0.030) and the medium risk (p = 0.050) in the NGT group.
CONCLUSIONS: The results suggest that in Asian Indians, (i) the diabetes risk score increases with increasing glucose intolerance, and (ii) it can serve as an effective indicator of metabolic syndrome and cardiovascular risk even among subjects with NGT.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17391160     DOI: 10.1111/j.1463-1326.2006.00612.x

Source DB:  PubMed          Journal:  Diabetes Obes Metab        ISSN: 1462-8902            Impact factor:   6.577


  30 in total

Review 1.  Nonpharmacological interventions for the prevention of type 2 diabetes mellitus.

Authors:  Peter E Schwarz; Colin J Greaves; Jaana Lindström; Thomas Yates; Melanie J Davies
Journal:  Nat Rev Endocrinol       Date:  2012-01-17       Impact factor: 43.330

2.  A simple Indian diabetes risk score could help identify nondiabetic individuals at high risk of non-alcoholic fatty liver disease (CURES-117).

Authors:  Viknesh Prabu Anbalagan; Vijayachandrika Venkataraman; Mamilla Vamsi; Mohan Deepa; Viswanathan Mohan
Journal:  J Diabetes Sci Technol       Date:  2012-11-01

3.  Association of Indian Diabetes Risk Score with arterial stiffness in Asian Indian nondiabetic subjects: the Chennai Urban Rural Epidemiology Study (CURES-84).

Authors:  Viswanathan Mohan; Kuppan Gokulakrishnan; Anbazhagan Ganesan; Srivastava Brijendra Kumar
Journal:  J Diabetes Sci Technol       Date:  2010-03-01

4.  Indian Diabetes Risk Score helps to distinguish type 2 from non-type 2 diabetes mellitus (GDRC-3).

Authors:  Kunal M Sharma; Harish Ranjani; Ha Nguyen; Shuba Shetty; Manjula Datta; K M Venkat Narayan; Viswanathan Mohan
Journal:  J Diabetes Sci Technol       Date:  2011-03-01

5.  Value of Indian Diabetes Risk Score among Medical Students and Its Correlation with Fasting Plasma Glucose, Blood Pressure and Lipid Profile.

Authors:  Anand Vardhan; Adhikari Prabha M R; Kotian Shashidhar M; Nithya Shankar; Sandhya Gupta; Amruta Tripathy
Journal:  J Clin Diagn Res       Date:  2012-11

Review 6.  Who should we target for diabetes prevention and diabetes risk reduction?

Authors:  Susann Blüher; Jana Markert; Sabine Herget; Thomas Yates; Melanie Davis; Gabriele Müller; Thomas Waldow; Peter E H Schwarz
Journal:  Curr Diab Rep       Date:  2012-04       Impact factor: 4.810

7.  Circulating adiponectin mediates the association between omentin gene polymorphism and cardiometabolic health in Asian Indians.

Authors:  Karani Santhanakrishnan Vimaleswaran; Dhanasekaran Bodhini; Juanjie Jiang; Kandaswamy Ramya; Deepa Mohan; Coimbatore Subramanian Shanthi Rani; Nagarajan Lakshmipriya; Vasudevan Sudha; Rajendra Pradeepa; Ranjit Mohan Anjana; Viswanathan Mohan; Venkatesan Radha
Journal:  PLoS One       Date:  2021-05-12       Impact factor: 3.240

8.  LIPITENSION: Interplay between dyslipidemia and hypertension.

Authors:  Jamshed J Dalal; T N C Padmanabhan; Piyush Jain; Shiva Patil; Hardik Vasnawala; Ashish Gulati
Journal:  Indian J Endocrinol Metab       Date:  2012-03

9.  Glycemic thresholds for diabetes-specific retinopathy: implications for diagnostic criteria for diabetes.

Authors:  Stephen Colagiuri; Crystal M Y Lee; Tien Y Wong; Beverley Balkau; Jonathan E Shaw; Knut Borch-Johnsen
Journal:  Diabetes Care       Date:  2010-10-26       Impact factor: 19.112

10.  Expanding role of the Madras Diabetes Research Foundation - Indian Diabetes Risk Score in clinical practice.

Authors:  Viswanathan Mohan; Viknesh Prabu Anbalagan
Journal:  Indian J Endocrinol Metab       Date:  2013-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.